Perspectum Group plc (SCAN)
| Market Cap | 590.28M |
| Revenue (ttm) | 9.26M |
| Net Income (ttm) | -11.79M |
| Shares Out | 36.89M |
| EPS (ttm) | -0.32 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SCAN
Perspectum Group is a leading commercial-stage precision health company focused on democratizing high-quality care globally through the use of our proprietary digital technologies that enable healthcare providers to provide better care for patients. Our software products combine expertise in image formation, magnetic resonance (MR) image analysis and artificial intelligence (AI) to support healthcare provider diagnosis, treatment decision-making and monitoring of the progression of chronic metabolic diseases, multi-organ pathologies and cancer,...
Financial Performance
In 2020, SCAN's revenue was $8.61 million, an increase of 8.79% compared to the previous year's $7.91 million. Losses were -$13.07 million, 24.2% more than in 2019.
Financial StatementsNews
Perspectum Group IPO Registration Document (S-1)
Perspectum Group plc has filed to go public with an IPO on the NASDAQ.